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ABSTRACT
The industrial manufacturing of natural products for veterinary use represents a major weakness in the veterinary sector 
despite increased interest and the traditional ancestral knowledge that supports them. A cross-sectional, descriptive 
observational study was conducted to characterize the veterinary herbal products marketed worldwide during 2018 
and 2019. A comprehensive thematic search limited to the 2018-2019 period was performed in the ScienceDirect, 
Scopus, PubMed, Web of Science, ResearchGate, and Academic Search Complete databases. The investigation identified 
487 products registered in the global market manufactured by 54 companies, led by India, The Netherlands, and the 
United Kingdom. The market segments of animal production and phytomedicines were dominant with 73.7% and 53.0% 
of products, respectively. Cattle (22.2%), sheep-goats (16.2%), and canines (16.2%) were the most favored species. The 
most represented therapeutic indications were those intended to treat gastrointestinal disorders (30.47%), antimicrobials 
(16.66%), and antiparasitic agents (10.47%). The families Fabaceae, Lamiaceae, Asteraceae, Apiaceae, Malvaceae, 
and Rutaceae stood out because of their frequent use, encompassing 35.0% of the 137 declared species. Andrographis 
paniculata (Burm.f.) Nees and Withania somnifera (Lin) Dunal were the most important species. Oral formulations for 
internal use (72%) and liquids (51%) in 100 mL, 500 mL, and 1 L presentations showed the highest prevalence on the 
market. The global market for veterinary herbal products during the 2018-2019 period was relevant in the productive 
and medical animal sector. No differences were found between medicinal plant species used to formulate herbal products 
for human and animal use.
Keywords: Herbal product. Veterinary health. Pharmaceutical industry. Marketing. Phytotherapy.
RESUMO
A fabricação industrial de produtos naturais para uso animal é uma das grandes fragilidades do setor veterinário, apesar 
de um crescente interesse e do suporte dado pelos conhecimentos tradicionais ancestrais. Foi realizado um estudo 
observacional descritivo transversal para caracterizar os fitoterápicos veterinários comercializados mundialmente no 
período de 2018-2019 através de uma busca temática exaustiva nas bases de dados ScienceDirect, Scopus, PubMed, Web 
of Science, ResearchGate e Academic Search Complete. O estudo mostrou a existência de 487 produtos registrados no 
mercado mundial, fabricados por 54 empresas, lideradas pela Índia, Holanda e Reino Unido. Os segmentos Danimal 
produtivo e fitomedicamentos dominam o mercado com 73,7% e 53,0% dos produtos, respectivamente. Bovinos 
(22,2%), ovinos-cabras (16,2%) e caninos (16,2%) foram as espécies mais favorecidas. As indicações terapêuticas mais 
representadas foram aquelas destinadas à correção de distúrbios gastrointestinais (30,47%), antimicrobianos (16,66%) 
e antiparasitários (10,47%). Devido à alta frequência de uso, destacam-se as famílias Fabaceae, Lamiaceae, Asteraceae, 
Apiaceae, Malvaceae e Rutaceae, que compreendem 35,0% das 137 espécies declaradas a saber, Andrographis paniculata 
(Burm.f.) Nees e Withania somnífera (Lin) Dunal, são as mais importantes. Constatou-se que as formulações para uso 
interno via oral (72%) e líquida (51%) em embalagens de 100, 500 e 1000 mL são as que prevalecem no mercado. O 
mercado global de produtos fitoterápicos durante o período de 2018-2019 foi relevante para animais produtivos e o 
setor médico. Não foram encontradas diferenças entre as espécies de plantas medicinais utilizadas em formulações de 
produtos fitoterápicos para uso humano e animal.
Palavras-chave: Produto fitoterápico. Saúde veterinária. Indústria farmacêutica. Marketing. Fitoterapia.
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Introduction
The worldwide social, scientific, and economic changes 
during the last decades have led to important changes in 
relationships between humans and medicinal plants and 
animals. Considerable traditional veterinary knowledge 
has taken second place in modern medicine in many cases. 
Besides, its practitioners have been considered primitive, 
old-fashioned, superstitious, and promoters of witchcraft. 
After overcoming this negative reputation held by the scientific 
community, ethnoveterinary knowledge has been recognized 
as a complex set of elements, including concepts, beliefs, 
practices, skills, and experiences transmitted vertically or 
horizontally along with generations. It has been demonstrated 
that these practices and knowledge are essential in many 
areas of the world to guarantee the health of livestock and 
therefore the survival of pastoral or agropastoral communities 
(Abdul et al., 2020; Wanzala et al., 2005).
Currently, there is considerable interest in herbal 
products despite the availability of multiple synthetic 
chemicals intended for veterinary use (Martínez & 
Jiménez, 2017). Several factors explain this, including the 
search for alternative, effective, and economical solutions 
to unresolved global health problems such as microbial 
resistance; the promotion of rural development along with 
its biocultural heritage (Aziz et al., 2018a; Mutua et al., 
2020; Suroowan et al., 2017); and the similarities between 
veterinary and human ethnomedicine (Miara et al., 2019). 
Regardless of the reasons, the use of plant-based veterinary 
products as a therapeutic complement, or even as the 
only available option, has recently acquired tremendous 
importance in terms of animal welfare (Feyera et al., 2017; 
Lans, 2019; Sharma & Manhas, 2015; Yigezu et al., 2014).
The enthusiasm for herbal products occurs in difficult 
times, from the social, environmental, livestock, and health 
perspectives. The recent socio-economic changes, which 
have brought about rural displacement, deforestation, and 
the extinction of botanical knowledge, medicinal species, 
and practitioners, worsen this situation.
Moreover, there is an imminent increase in livestock 
production by 2050, associated with a demographic 
explosion, especially in urban areas, and the expected 70% 
increase in the global demand for animal protein. This 
unfavorable scenario includes microbiological threats, the 
emergence of zoonotic diseases, chemical residues in food, 
and increasingly demanding markets. Therefore, rescuing, 
preserving, and transmitting traditional values will be key 
for developing new and improved natural products, which 
could become a viable option for successfully addressing 
these challenges (Calixto, 2019; Cruz, 2011; Friedrich, 2014; 
Sen & Samanta, 2015).
In the face of this complex perspective, neither the 
ethnoveterinary literature nor the animal health industry 
is prepared to meet future requirements and opportunities. 
Traditional knowledge continues to be a useful resource 
that has not been fully exploited, and its implementation 
in the veterinary pharmaceutical industry is one of this 
industry’s major weaknesses. Therefore, pharmaceutical 
manufacturers worldwide need to monitor the behavior of 
the global market for veterinary herbal products as a step 
leading to implementing national development strategies. 
In this sense, this study was aimed at characterizing the 




A cross-sectional, descriptive observational study 
was performed from January to March 2020 to obtain an 
overview of the herbal veterinary products on the market. 
The starting point was a comprehensive thematic search 
in databases and online platforms (ScienceDirect, Scopus, 
PubMed, Web of Science, ResearchGate, and Academic 
Search Complete) limited to the 2018-2019 period.
Thematic strategy
The title, abstract, and keywords fields were used, along 
with specific search terms related to ethnoveterinary science 
(medicinal plants, traditional medicine, and veterinary 
herbal products) and animal health problems (infectious 
diseases, microbial resistance, and reproduction, among 
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others). It was aimed at excluding homeopathic products 
and stratifying the different species of domestic animals 
into productive and pets. Besides, we used combinations of 
terms often used to refer to the bovine (cattle, calf, bovine, 
cow, and calves), equine (horse, equine), porcine (pig, hog, 
swine, porcine, and piglets), sheep-goat (ovine, sheep, 
caprine, goat, and goatish), bird (bird, avian, pigeon, and 
poultry), canine (pets, dog, and canine), and feline (pets, 
cats, and feline) species.
Variables studied
The generated database considered the following 
parameters: companies in the sector (name and country of 
origin); type of herbal product (phytomedicines, phytogenic 
additives, or natural nutraceuticals); animal species category, 
productive (bovine, equine, pig, sheep-goat, or poultry), 
or pet (dog or cat); plant species (scientific name, family, 
formulations, and frequency of use); route of administration 
(oral or external application); pharmaceutical form (liquid, 
solid, or semisolid), and presentation.
Inclusion criteria
- Having declared the natural active ingredient (medical 
plant) used in the formulation.
- Having shown indications of use in productive 
terrestrial animals and pets.
Data analysis
Microsoft® Excel® was used to organize and analyze the 
downloaded data. Descriptive statistics (percentage, frequency, 
and the 25th and 75th percentiles) were performed using 
the SPSS software, version 12.0.
Results and Discussion
A detailed analysis of the veterinary herbal product 
market demonstrated the wide variety of products included 
in it. The presence of 487 products legally authorized 
for commercialization during the 2018-2019 period was 
identified. The productive-commercial universe was 
composed of 54 companies, of which Ayurvet Ltd, Himalaya 
Drug Company, Amorvet, Kamal Ayurvedic Herbs (India), 
the ECOstyle Group (Holland), and Dorwest Herbs Ltd. 
(UK) were the best positioned. These results suggest that 
this sector of the veterinary market is large, attractive, and 
beyond the scope of the large international biopharmaceutical 
companies based in the United States, Germany, and France 
(Domínguez et al., 2014).
Globally, the market for veterinary herbal products is 
segmented by animal species (productive or pet) and type of 
product (phytomedicines, phytogenic additives, or natural 
nutraceuticals). Figure 1 shows the market share for both 
segments with productive animals being prevalent (73.7%), 
followed by pets (26.3%). Phytomedicines represented the 
largest market share with 53.0% of the products sold, and 
the remaining 47.0% belonging to the food line. Within the 
latter category, phytogenic additives were the best positioned 
(55.8%), followed by natural nutraceuticals (44.2%).
These results show that this market is somewhat more 
complex than initially thought. Bovine cattle (22.2%) 
were identified as the leading animal species, followed by 
sheep-goats (16.2%) and canines (16.2%). An analysis by the 
type of product and species showed that the phytomedicines 
maintained the same previous order, unlike the additive 
products (canines: 23.3%, bovines: 20.9%, and cats: 16.3%) 
and nutraceuticals (bovines: 22.0%, poultry: 20.0%, and 
sheep-goats: 19.0%).
The disproportion observed in the veterinary herbal 
product market in favor of productive animals and the 
medical sector was expected. The reasons are based on the 
ancestral requirement for using medicinal plants to ensure 
the health of the herd, the production of animal protein, and 
thus, the subsistence of agropastoral communities. Besides, 
the chemicals generated by modern veterinary medicine 
are often expensive and veterinary services are not always 
available to farmers (Feyera et al., 2017; Suroowan et al., 
2017). Also, resistance is generated by microorganisms and 
the quality of animal protein is reduced. The popularity of 
phytomedicines intended for use in bovines and sheep-goats 
is proportional to the weight that these species have in 
the production of meat, milk, cheese, and leather. The 
husbandry of these three polygastric animals is essential 
both for household survival and for increasing economic 
capital and social prestige in pastoralist and peasant societies 
(McGaw et al., 2020; Tilahun et al., 2019).
Figure 1 – Global share of veterinary herbal products on the 
market based on animal species and type of product 
during the 2018-2019 period.
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Despite the overwhelming dominance of the productive 
species, it is important to point out the presence of pets 
in the medical and food sectors, with dominance in 
phytogenic additives. It can be inferred, therefore, that there 
is awareness regarding the health and well-being of pets. 
This is associated with the progressive change observed 
concerning the public perception of raising companion 
animals, thus provoking a greater demand for general care, 
food, and hygiene services. Pets today have lost their function 
as working animals (protecting homes and livestock, and 
hunting for mice) and have acquired the social function 
of providing company. The growing body of scientific 
data shows certain factors that lead to these changes are 
primarily related to the evident positive physical, social, 
and emotional impact (promoter of mental health) that 
possessing a pet provokes in interpersonal relationships 
and in families with members who are traumatized, 
stressed, or have chronic health problems (Bibbo  et  al., 
2019; Lass-Hennemann et al., 2020). However, there is a 
false belief that herbal products have fewer undesirable side 
effects compared to those of synthetic origin because they 
are natural (Mengual-Moreno et al., 2015).
An asymmetric behavior among the 210 phytomedicines 
was seen when grouping them in ascending order, which 
is an aspect that cannot be separated from the previous 
characteristics. Figure 2 summarizes the representativeness 
of each phytomedicine and shows that the products to treat 
gastrointestinal disorders, antimicrobials, and antiparasitic 
agents are represented the most. They individually represent 
30.47%, 16.66%, and 10.47% of the products positioned 
in the market, and as a whole reach 57.6% of all herbal 
products manufactured for medical purposes.
The dominant medical indications show remarkable 
consistency with health requirements and ethnoveterinary 
practices in livestock communities in Africa, Asia, Europe, 
and America (Abdul  et  al., 2020; Calzetta  et  al., 2020; 
Lans, 2019; Martínez & Jiménez, 2017; Miara et al., 2019; 
Stucki et al., 2019; Suroowan et al., 2017). Additionally, there 
is correspondence to the diseases with the greatest effect 
on productive and reproductive performance of productive 
animals in general, and especially polygastric animals at 
early ages, such as diarrhea and bloating (tympanites) 
(Ayrle  et  al., 2016; Charlier  et  al., 2020; Figueroa  et  al., 
2018; Swartz et al., 2020).
The considerable use of herbal products with antimicrobial 
and antiparasitic properties reaffirmed their relevance to 
current veterinary practice. From the “one health, one 
medicine” perspective they deserve special attention 
for their contributions to the control and treatment of 
infectious-contagious diseases, the increase in organic 
livestock production, and for their potential to lower the use of 
synthetic products in animals and humans (Hernández et al., 
2018; McEwen & Collignon 2018; Mertenat et al., 2020). 
Another remarkable aspect is their ability to decrease 
microbial virulence, growth, and development of resistance. 
This is attributed to their numerous secondary metabolites 
that attack microorganisms at the same time and through 
different pathways when strengthening or in synergy with 
each other (Hernández et al., 2018; Peng et al., 2017).
The special position of these two types of drugs in the 
market is not coincidental. However, it occurs at a time 
when the human and veterinary pharmaceutical industry, 
farmers, and researchers seek solutions to the serious issue 
of antimicrobial resistance (Collignon & McEwen, 2019; 
Iannino  et  al., 2019). The reasons for this cooperation 
are the rapid expansion of resistance associated with the 
globalization of trade, a decrease in therapeutic options to 
combat it, an increase in productive-reproductive losses 
because of high morbidity and mortality, and the possibility 
of transferring resistant microorganisms of animal origin 
to humans (Astorga  et  al., 2019; Feiyang  et  al., 2019; 
Mutua et al., 2020; Van Boeckel et al., 2019).
The analysis of the formulations made it possible to 
acknowledge the wide and valuable ethnobotanical knowledge 
that underlies each herbal product. The inventory yielded 
68 botanical families, which include a wide variety and quantity 
of plant species. Figure 3 shows the main botanical families 
that form the catalog. The families Fabaceae, Lamiaceae, 
Asteraceae, Apiaceae, Malvaceae, and Rutaceae were the 
most frequent and together constitute 35.0% (48/137) of 
the species used. These results are largely consistent with 
the results from other international ethnobotanical and 
ethnopharmacological studies, which not only highlight 
these families but also provide extensive documentation 
and a scientific assessment on the chemical composition 
and biological activity of the species grouped within them 
Figure 2 – Veterinary phytomedicines present on the market based 
on therapeutic indication during the 2018-2019 period.
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(Abdelhafez et al., 2020; Abdul et al., 2020; Bhadane et al., 
2018; Coimbra et al., 2020; Miara et al., 2019; Nisar et al., 
2018; Sharifi-Rad et al., 2020; Suroowan et al., 2017).
Two interesting aspects were identified: The 137 plant 
species used generally have an extensive distribution and 
habitat, and 50% of the commercialized products are 
composed of one to three plants. The combined use of 
medicinal plants in a formulation is not surprising, since it 
is done to increase the product’s therapeutic efficacy by the 
strengthening or synergy mentioned above (Hernández et al., 
2018; Pietruszewska et al., 2018). This strategy, in general 
terms, is not exclusive to herbal products but is performed 
by large biopharmaceutical companies. Polyvalent vaccines 
formulated with several antigens are the best example 
(Domínguez et al., 2014). By protecting against multiple 
diseases simultaneously, they are the best way to reduce 
the manipulation of animals, lower costs, and shorten 
vaccination programs (McVey & Shi, 2010).
Considering a large number of medicinal plant species 
identified that would be very extensive to analyze, reference 
will be made only to species with a high and medium level 
of use in formulations (Table  1). The results suggested 
that 100% of the reported plant species, far from being 
of exclusive veterinary use, were extensively used in 
humans (Bijak, 2017; Dewangan et al., 2020; Fourati et al., 
2020; Gucwa et  al., 2018; Hossain & Mizanur Rahman, 
2019; Javir & Joshi, 2019; Lu et al., 2019; Ma et al., 2020; 
Murugan et al., 2020; Nigam et al., 2020; Rose et al., 2019; 
Singh et al., 2019; Sabir et al., 2020; Saggam et al., 2020; 
Santhan, 2020; Saha et al., 2020; Singh & Geetanjali, 2016; 
Yadav et al., 2020; Yu et al., 2020; Zhang et al., 2020). The 
pronounced convergence found evinces the similarities 
between ethnomedical and ethnoveterinary knowledge 
(Miara  et  al., 2019) and reinforces the “one health, one 
medicine” concept.
Andrographis paniculata and Withania somnifera stand 
out from the 21 plant species identified with high and 
medium levels of use in formulations, thus reflecting their 
wide therapeutic potential and commercial value (Santhan, 
2020). Both share similar pharmacological activities in 
humans with antimicrobial, antitumor, hypoglycemic, and 
anti-inflammatory activities associated with the action of 
andrographolide and withaferin, respectively (Dai et al., 
2019; Dutta et al., 2019; Saggam et al., 2020; Zhang et al., 
2020). Several authors have demonstrated the usefulness 
of A. paniculata as both an antiparasitic and antiviral 
agent in veterinary medicine (Elango & Rahuman, 2011; 
Sornpet et al., 2017), whereas W. somnifera excels against 
urinary disorders and as an antipyretic agent (Aziz et al., 
2018b; Feyera et al., 2017).
In terms of the route of administration, the formulations 
present on the market for internal use by oral route prevail 
over those for external application (72% vs. 28%). Similarly, 
liquid presentations predominate (51%) in 100 mL, 500 mL, 
and 1 L presentations; followed by solids (46%) in the 
form of powders packed in bags of 1, 20, 25, and 50 kg; 
and finally, the semisolids (3%). The predominance of the 
oral route and liquid presentations is not very surprising, 
and this behavior is consistent with studies conducted in 
Figure 3 – Botanical families most represented in the catalog 
of medicinal plants of the leading companies during 
the 2018-2019 period.
Table 1 – Catalog of medicinal plants with high and medium 





High Andrographis paniculata (Burm.f.) 
Nees
16
Withania somnifera (L.) Dunal 16
Asparagus racemosus, Willd 14
Emblica officinalis, Gaertn 14
Zingiber officinale, Rosc 14
Ocimum basilicum, Lin 13
Azadirachta indica, A. Juss 13
Tinospora cordifolia, (Thunb.) Miers 12
Ocimum sanctum, Lin 11
Medium Silybium marianum, (L.) Gaertn 9
Terminalia chebula, Retz 8
Phyllanthus niruri, Lin 8
Allium sativum, Lin 8
Acacia catechu, (Willd.) Wight & Arn 7
Bacopa monnieri, (L.) Wettst 7
Boerhaavia diffusa, Lin 7
Cyperus rotundus, Lin 7
Eclipta prostrata, (L.) Lin 7
Picrorhiza kurroa, Royle ex Benth 7
Piper longum, Lin 7
Punica granatum, Lin 7
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agropastoral communities (Feyera et al., 2017; Martínez 
& Jiménez, 2017; Mertenat et al., 2020; Suroowan et al., 
2017). Another feature that supports the use of liquid 
forms is their advantage of higher absorption rate of the 
active principles compared to other forms of presentation, 
and the number of active ingredients they contain, which 
is generally higher than that found naturally in the plant 
(Tiwari et al., 2011).
Conclusions
1. The global market for veterinary herbal products 
during the 2018-2019 period was relevant in the 
productive and medical animal sector;
2.	 No	differences	were	 found	between	medicinal	 plant	
species used to formulate herbal products for human 
and animal use.
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